ILF2 and neoplasm: Tumor-versus-normal overexpression further refined a nine-TF panel—ILF2, HMGA1, FOXM1, ETV4, E2F1, MYBL2, HTATIP2, DDIT3, and HES6—consistently upregulated in tumors and associated with adverse prognosis (Figure S1F).